Research Output per year
Research Output per year
Personal profile
Certifications and Licenses
| Pediatrics |
Training Experience
| 1978 | Residency, Univ. of Illinois at Chicago |
| 1980 | Fellowship, Northwestern University, McGaw Medical Center (Children’s Memorial Hospital) |
| 1981 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
Medicine, MD, University of Illinois at Chicago
… → 1975
Fingerprint
Dive into the research topics where Horace E Smith II is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research Output
- 4 Article
-
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors
Lusher, J. M., Roberts, H. R., Davignon, G., Joist, J. H., Smith, H., Shapiro, A., Laurian, Y., Kasper, C. K. & Mannucci, P. M., 1998, In: Haemophilia. 4, 6, p. 790-798 9 p.Research output: Contribution to journal › Article › peer-review
202 Scopus citations -
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors
Key, N. S., Aledort, L. M., Beardsley, D., Cooper, H. A., Davignon, G., Ewenstein, B. M., Gilchrist, G. S., Gill, J. C., Glader, B., Hoots, W. K., Kisker, C. T., Lusher, J. M., Rosenfield, C. G., Shapiro, A. D., Smith, H. & Taft, E., Dec 1998, In: Thrombosis and Haemostasis. 80, 6, p. 912-918 7 p.Research output: Contribution to journal › Article › peer-review
354 Scopus citations -
Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia a patients with inhibitors
Schmidt, M. L., Gamerman, S., Smith, H. E., Scott, J. P. & DiMichele, D. M., Sep 1994, In: American Journal of Hematology. 47, 1, p. 36-40 5 p.Research output: Contribution to journal › Article › peer-review
64 Scopus citations -
PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR‐IX‐DEFICIENT PATIENT WITH AN INHIBITOR
Schmidt, M. L., Smith, H. E., Gamerman, S., DiMichele, D., Glazer, S. & Scott, J. P., Jul 1991, In: British Journal of Haematology. 78, 3, p. 460-463 4 p.Research output: Contribution to journal › Article › peer-review
19 Scopus citations